Literature DB >> 14752466

Assessment of coronary flow reserve and microcirculation: a clinical perspective.

Roxana Campisi, Marcelo F Di Carli.   

Abstract

Mesh:

Year:  2004        PMID: 14752466     DOI: 10.1016/j.nuclcard.2003.11.003

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  65 in total

1.  Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus.

Authors:  M F Di Carli; D Bianco-Batlles; M E Landa; A Kazmers; H Groehn; O Muzik; G Grunberger
Journal:  Circulation       Date:  1999-08-24       Impact factor: 29.690

2.  Altered myocardial vasodilatation in patients with hypertriglyceridemia in anatomically normal coronary arteries.

Authors:  I Yokoyama; T Ohtake; S Momomura; K Yonekura; N Kobayakawa; T Aoyagi; S Sugiura; Y Sasaki; M Omata
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-02       Impact factor: 8.311

3.  Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes.

Authors:  Marcelo F Di Carli; James Janisse; George Grunberger; Joel Ager
Journal:  J Am Coll Cardiol       Date:  2003-04-16       Impact factor: 24.094

4.  Noninvasive assessment of coronary microcirculatory function in postmenopausal women and effects of short-term and long-term estrogen administration.

Authors:  Roxana Campisi; Lauren Nathan; Miguel Hernandez Pampaloni; Heiko Schöder; James W Sayre; Gautam Chaudhuri; Heinrich R Schelbert
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

5.  Coronary heart disease in smokers: vitamin C restores coronary microcirculatory function.

Authors:  P A Kaufmann; T Gnecchi-Ruscone; M di Terlizzi; K P Schäfers; T F Lüscher; P G Camici
Journal:  Circulation       Date:  2000-09-12       Impact factor: 29.690

6.  Reduction of coronary flow reserve in areas with and without ischemia on stress perfusion imaging in patients with coronary artery disease: a study using oxygen 15-labeled water PET.

Authors:  Keiichiro Yoshinaga; Chietsugu Katoh; Kazuyuki Noriyasu; Yasuyoshi Iwado; Hideto Furuyama; Yoshinori Ito; Yuji Kuge; Tetsuro Kohya; Akira Kitabatake; Nagara Tamaki
Journal:  J Nucl Cardiol       Date:  2003 May-Jun       Impact factor: 5.952

7.  Myocardial blood flow and flow reserve in response to short-term cyclical hormone replacement therapy in postmenopausal women.

Authors:  C S Duvernoy; J Rattenhuber; V Seifert-Klauss; F Bengel; C Meyer; M Schwaiger
Journal:  J Gend Specif Med       Date:  2001

8.  Delayed response of myocardial flow reserve to lipid-lowering therapy with fluvastatin.

Authors:  M Guethlin; A M Kasel; K Coppenrath; S Ziegler; W Delius; M Schwaiger
Journal:  Circulation       Date:  1999-02-02       Impact factor: 29.690

9.  Prediction of the physiologic significance of coronary arterial lesions by quantitative lesion geometry in patients with limited coronary artery disease.

Authors:  R F Wilson; M L Marcus; C W White
Journal:  Circulation       Date:  1987-04       Impact factor: 29.690

10.  Early impairment of coronary flow reserve in young men with borderline hypertension.

Authors:  H Laine; O T Raitakari; H Niinikoski; O P Pitkänen; H Iida; J Viikari; P Nuutila; J Knuuti
Journal:  J Am Coll Cardiol       Date:  1998-07       Impact factor: 24.094

View more
  18 in total

1.  Endothelial dysfunction in patients with antiphospholipid syndrome assessed with positron emission tomography.

Authors:  Erick Alexanderson; Patricio Cruz; Angélica Vargas; Aloha Meave; Alejandro Ricalde; Jose A Talayero; José Luis Romero-Ibarra; Tovë M Goldson; Olga L Vera-Lastra; Gabriela Medina; Luis Jara; Mary-Carmen Amigo
Journal:  J Nucl Cardiol       Date:  2007-07-02       Impact factor: 5.952

Review 2.  Advances in positron emission tomography.

Authors:  Marcelo F Di Carli
Journal:  J Nucl Cardiol       Date:  2004 Nov-Dec       Impact factor: 5.952

3.  Should PET replace SPECT for evaluating CAD? The end of the beginning.

Authors:  Marcelo F Di Carli; Rory Hachamovitch
Journal:  J Nucl Cardiol       Date:  2006 Jan-Feb       Impact factor: 5.952

4.  Hybrid PET/CT is greater than the sum of its parts.

Authors:  Marcelo F Di Carli; Rory Hachamovitch
Journal:  J Nucl Cardiol       Date:  2008 Jan-Feb       Impact factor: 5.952

Review 5.  Myocardial perfusion quantitation with PET: time to do our homework.

Authors:  Eva Fricke
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-10       Impact factor: 9.236

6.  Coronary vasodilator reserve and Framingham risk scores in subjects at risk for coronary artery disease.

Authors:  Sharmila Dorbala; Alita Hassan; Therese Heinonen; Heinrich R Schelbert; Marcelo F Di Carli
Journal:  J Nucl Cardiol       Date:  2006-11       Impact factor: 5.952

7.  Measurement of MBF by PET is ready for prime time as an integral part of clinical reports in diagnosis and risk assessment of patients with known or suspected CAD-PRO.

Authors:  Marcelo F Di Carli
Journal:  J Nucl Cardiol       Date:  2017-08-22       Impact factor: 5.952

8.  Beneficial effects of atorvastatin on myocardial regions with initially low vasodilatory capacity at various stages of coronary artery disease.

Authors:  Peter Wielepp; Detlev Baller; Ulrich Gleichmann; Ewa Pulawski; Dieter Horstkotte; Wolfgang Burchert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-08-31       Impact factor: 9.236

9.  Endothelial dysfunction in recently diagnosed type 2 diabetic patients evaluated by PET.

Authors:  Erick Alexanderson; Mónica Rodriguez-Valero; Alfonso Martinez; Rodrigo Calleja; Pedro A Lamothe; Carlos Sierra; Leonardo Garcia-Rojas; Jose Antonio Talayero; Patricio Cruz; Aloha Meave; Graciela Alexanderson
Journal:  Mol Imaging Biol       Date:  2008-09-03       Impact factor: 3.488

10.  Quantitative relationship between coronary calcium content and coronary flow reserve as assessed by integrated PET/CT imaging.

Authors:  Zelmira Curillova; Bettina F Yaman; Sharmila Dorbala; Raymond Y Kwong; Arkadius Sitek; Georges El Fakhri; Constantinos Anagnostopoulos; Marcelo F Di Carli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-04-22       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.